Oxytrex: Phase III completed enrollment

PTIE completed enrollment of over 700 patients in a double-blind, U.S. Phase III trial. Patients will receive either placebo, oxycodone 4 times a day, Oxytrex 4 times a day or Oxytrex twice daily for ...